NASHVILLE, Tenn.--(BUSINESS WIRE)--LP Building Solutions (“LP”) (NYSE: LPX) today announced that it will release financial results for the fourth quarter and year-end 2023 on Wednesday, February 14, ...
CHICAGO, IL—Two new drugs targeting lipoprotein(a)—one a small interfering RNA (siRNA), the other an oral agent that prevents its formation—both showed positive results in early phase II studies, with ...
High levels of lipoprotein(a) (Lp(a)) are a genetically determined independent risk factor for cardiovascular disease that cannot be modified through lifestyle changes. Now, a study in Nature reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results